Acute Schizophrenia | 18-65 | Inpatient | Earn up to $11,700
Segal Trials is currently conducting an inpatient clinical research study to evaluate the safety and efficacy of treatment for patients with Schizophrenia.
Study Details
• Adults between the ages of 18 and 65
• May be experiencing an Acute exacerbation or relapse in symptoms
• Must have been on an antipsychotic for at least 6 weeks at an adequate dose in the past year
• Study length: up to 9 weeks
Participants who qualify may receive:
• Complimentary study-related exams
• Available transportation
• Compensation up to $11,700 for your time and travel
• No insurance is necessary!